Trials / Unknown
UnknownNCT05815394
177Lu-labeled NY108 SPECT Imaging in Patients
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Affiliated Hospital of Jiangnan University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a single arm study to evaluate the safety and biodistribution of 177Lu-labeled NY108 (177Lu-NY108) SPECT Imaging in patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 177Lu-labeled NY108 | Patients will receive a tracer (40-60ug) dose of 177Lu(28.5-31.5mCi) labelled NY108. |
Timeline
- Start date
- 2023-03-03
- Primary completion
- 2024-03-03
- Completion
- 2024-12-12
- First posted
- 2023-04-18
- Last updated
- 2023-04-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05815394. Inclusion in this directory is not an endorsement.